Delving into Matrix Metalloproteinase-1 (MMP-1) and its Significance in Periodontal Diseases.
Autor: | Natarajan PM; Department of Clinical Sciences, College of Dentistry, Centre of Medical and Bio-Allied Health Sciences and Research, Ajman University, Ajman, UAE., Ganesan A; Department of Oral Medicine and Radiology, SRM Dental College, Ramapuram, Chennai, Tamil Nadu, India., Varma SR; Department of Clinical Sciences, College of Dentistry, Centre of Medical and Bio-Allied Health Sciences and Research, Ajman University, Ajman, UAE., Shetty NY; Department of Clinical Sciences, College of Dentistry, Centre of Medical and Bio-Allied Health Sciences and Research, Ajman University, Ajman, UAE. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of pharmacy & bioallied sciences [J Pharm Bioallied Sci] 2024 Apr; Vol. 16 (Suppl 2), pp. S1080-S1083. Date of Electronic Publication: 2024 Apr 16. |
DOI: | 10.4103/jpbs.jpbs_1249_23 |
Abstrakt: | Matrix metalloproteinase-1 (MMP-1) plays a pivotal role in the pathogenesis of periodontal diseases, particularly periodontitis, by virtue of its collagenolytic activity targeting collagen type I, the primary component of periodontal tissues. This review abstract elucidates the intricate involvement of MMP-1 in periodontal tissue homeostasis and its dysregulation in disease states. Elevated MMP-1 levels, observed in gingival tissues and crevicular fluid of individuals with periodontitis, correlate with the degradation of collagen fibers within the periodontium. This degradation contributes to the detachment of teeth from surrounding tissues and exacerbates alveolar bone resorption, hallmark features of periodontal breakdown. Therapeutically, targeting MMP-1 activity emerges as a promising strategy, prompting ongoing research into MMP inhibitors and host modulation therapies. Understanding MMP-1's nuanced role in periodontal diseases paves the way for personalized treatment approaches and holds promise in reshaping periodontal disease management for improved patient outcomes and periodontal health. Competing Interests: There are no conflicts of interest. (Copyright: © 2024 Journal of Pharmacy and Bioallied Sciences.) |
Databáze: | MEDLINE |
Externí odkaz: |